GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash and Bank History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹1,176 Cr | ₹1,705 Cr | ₹1,659 Cr | ₹1,160 Cr | ₹1,412 Cr |
What is the latest Cash and Bank ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash and Bank |
|---|---|
| Mar2026 | ₹1,176 Cr |
| Mar2025 | ₹1,705 Cr |
| Mar2024 | ₹1,659 Cr |
| Mar2023 | ₹1,160 Cr |
| Mar2022 | ₹1,412 Cr |
How is Cash and Bank of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,176 Cr | -31.02 | |
| Mar2025 | ₹1,705 Cr | 2.76 | |
| Mar2024 | ₹1,659 Cr | 43.02 | |
| Mar2023 | ₹1,160 Cr | -17.80 | |
| Mar2022 | ₹1,412 Cr | - | |
Compare Cash and Bank of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹62,333.7 Cr | -2.6% | -8.5% | 16.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -2.6% |
-8.5% |
16.4% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses